Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14-18, 2012

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 2, 2013, Pages 96-121

  Anderson Schmidt, Heike ^a   Beltcheva, Olga ^b   Brandon, Mariko D ^c   Byrne, Enda M ^d   Diehl, Eric J ^e   Duncan, Laramie ^f   Gonzalez, Suzanne D ^g   Hannon, Eilis ^h   Kantojärvi, Katri ⁱ   Karagiannidis, Iordanis ^j   Kos, Mark Z ^k   Kotyuk, Eszter ^l   Laufer, Benjamin I ^e   Mantha, Katarzyna ^e   Mcgregor, Nathaniel W ^m   Meier, Sandra ⁿ   Nieratschker, Vanessa ^o   Spiers, Helen ^p   Squassina, Alessio ^q   Thakur, Geeta A ^r   Tiwari, Yash ^s   Viswanath, Biju ^t   Way, Michael J ^u   Wong, Cybele C P ^p   O'Shea, Anne ^v   Delisi, Lynn E ^v   more..

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^h CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^k SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^l EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^m UNIVERSITY OF STELLENBOSCH   (South Africa)

ⁿ UNIVERSITY OF HEIDELBERG   (Germany)

^o MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^p MEDICAL RESEARCH COUNCIL   (United Kingdom)

^q UNIVERSITY OF CAGLIARI   (Italy)

^r DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^s NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^t NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^u UNIVERSITY COLLEGE LONDON   (United Kingdom)

^v VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

DNA; International Society of Psychiatric Genetics; Pharmacogenomics; PTSD; SCZ; Sequencing; Substance abuse; World Congress of Psychiatric Genetics

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BREAST CANCER RESISTANCE PROTEIN; CENTRAL STIMULANT AGENT; DEXAMETHASONE; DNA; DOPAMINE 2 RECEPTOR; FK 506 BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRINOTECAN; LONG UNTRANSLATED RNA; MESSENGER RNA; RETINA S ANTIGEN; SALVINORIN A; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AGGRESSION; ALCOHOL CONSUMPTION; ALCOHOLISM; ALZHEIMER DISEASE; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; BRAIN REGION; COMORBIDITY; COMPARATIVE STUDY; DEMETHYLATION; DEPRESSION; DISEASE PREDISPOSITION; DNA METHYLATION; DRUG DEPENDENCE; EATING DISORDER; ENDOPHENOTYPE; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENERALIZED ANXIETY DISORDER; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HERITABILITY; HLA SYSTEM; HUMAN; IMMUNOGENETICS; IN VIVO STUDY; INTELLECTUAL IMPAIRMENT; LEARNING DISORDER; MAJOR DEPRESSION; MEDICAL SOCIETY; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; PANIC; PHENOTYPE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSIS; QUANTITATIVE TRAIT LOCUS; RECURRENCE RISK; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; ENDOPHENOTYPES; EPIGENESIS, GENETIC; GENETIC TESTING; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GERMANY; HUMANS; INHERITANCE PATTERNS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; MICE; SEQUENCE ANALYSIS, DNA;

EID: 84874147456     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32132     Document Type: Article

References (106)

1. Alkelai A, Baum A, Carless M, Crowley J, Dasbanerjee T, Dempster E, Docherty S, Hare E, Galsworthy MJ, Grover D, Glubb D, Karlsson R, Mill J, Sen S, Quinones MP, Vallender EJ, Verma R, Vijayan NN, Villafuerte S, Voineskos AN, Volk H, Yu L, Zimmermann P, Delisi LE. 2008. The XVth World Congress of Psychiatric Genetics, October 7-11, 2007: Rapporteur summaries of oral presentations. Am J Med Genet Part B Neuropsychiatr Genet 147B:233-277.
2. Allen JA, Yost JM, Setola V, Chen X, Sassano MF, Chen M, Peterson S, Yadav PN, Huang XP, Feng B, Jensen NH, Che X, Bai X, Frye SV, Wetsel WC, Caron MG, Javitch JA, Roth BL, Jin J. 2011. Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci USA 108(45):18488-18493.
3. Amstadter AB, Balachandar V, Bergen SE, Ceulemans S, Christensen JH, Cole J, De Luca V, Ducci F, Tee SF, Hartz S, Keers R, Medland S, Melas PA, Mühleisen TW, Ozomaro U, Pidsley R, Scott AP, Sha L, Talati A, Teltsh O, Videtič A, Wang K, Wong CC, Delisi LE. 2010. Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009. Psychiatr Genet 20(5):229-268.
4. Amunts K, Zilles K. 2001. Advances in cytoarchitectonic mapping of the human cerebral cortex. Neuroimaging Clin N Am 11(2):151-169; vii.
5. Amunts K, Malikovic A, Mohlberg H, Schormann T, Zilles K. 2000. Brodmann's areas 17 and 18 brought into stereotaxic space-where and how variable? Neuroimage 11(1):66-84.
6. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. 2003. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6(2):115-116.
7. Axer M, Amunts K, Grassel D, Palm C, Dammers J, Axer H, Pietrzyk U, Zilles K. 2011a. A novel approach to the human connectome: Ultra-high resolution mapping of fiber tracts in the brain. Neuroimage 54(2):1091-1101.
8. Baune BT, Dannlowski U, Domschke K, Janssen DG, Jordan MA, Ohrmann P, Bauer J, Biros E, Arolt V, Kugel H, Baxter AG, Suslow T. 2010. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67:543-549.
9. Bennett AJ, Lesch KP, Heils A, Long JC, Lorenz JG, Shoaf SE, Champoux M, Suomi SJ, Linnoila MV, Higley JD. 2002. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 7:118-122.
10. Bergen S, Chen J, Dagdan E, Foon TS, Goes FS, Houlihan LM, Kloiber S, Kumar RA, Kuzman MR, Menke A, Pedroso I, Videtic A, Villafuerte S, DeLisi LE. 2009. Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11-15 October 2008. Psychiatr Gen 19:219-236.
11. Bergen SE, Balhara YP, Christoforou A, Cole J, Degenhardt F, Dempster E, Fatjó-Vilas M, Khedr Y, Lopez LM, Lysenko L, McGrath LM, Mühleisen TW, Neves FS, Nymberg C, Ozomaro U, Verweij KJ, Voineskos AN, Zai CC, O'Shea A, DeLisi LE. 2011. Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3-7 October 2010. Psychiatr Genet 21(3):136-172.
12. Bozdagi O, Sakurai T, Dorr N, Pilorge M, Takahashi N, Buxbaum JD. 2012. Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. PLoS ONE 7(8):e42422.
13. Bradshaw NJ, Porteous DJ. 2011. DISC1-binding proteins in neural development, signaling and SCZ. Neuropharmacology 62(3):1230-1241.
14. Brandon NJ, Sawa A. 2011. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci England 12(12):707-722.
15. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Cole D, Kessler RM, Zald DH. 2010. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci 13(4):419-421.
16. Carless MA, Glahn DC, Johnson MP, Curran JE, Bozaoglu K, Dyer TD, Winkler AM, Cole SA, Almasy L, MacCluer JW, Duggirala R, Moses EK, Goring HH, Blangero J. 2011. Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes. Mol Psychiatry 16:1096-1104; 1063.
17. Caspers S, Schleicher A, Bacha-Trams M, Palomero-Gallagher N, Amunts K, Zilles K. 2012. Organization of the human inferior parietal lobule based on receptor architectonics. Cereb Cortex [Epub ahead of print].
18. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
19. Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM. 2008. Set-shifting ability and SCZ: A marker of clinical illness or an intermediate phenotype? Biol Psychiatry 64(9):782-788.
20. Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. 2006. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 163(7):1282-1284.
21. Chen X, Sassano MF, Zheng L, Setola V, Chen M, Bai X, Frye SV, Wetsel WC, Roth BL, Jin J. 2012. Structure-functional selectivity relationship studies of beta-arrestin-biased dopamine D(2) receptor agonists. J Med Chem 55(16):7141-7153.
22. Cheng R, Abney M, Palmer AA, Skol AD. 2011. QTLRel: An R package for genome-wide association studies in which relatedness is a concern. BMC Genet 12:66.
23. Chiocchetti A, Pakalapati G, Duketis E, Wiemann S, Poustka A, Poustka F, Klauck SM. 2011. Mutation and expression analyses of the ribosomal protein gene RPL10 in an extended german sample of patients with autism spectrum disorder. Am J Med Genet Part A 155A:1472-1475.
24. Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. 2008. The DISC locus in psychiatric illness. Mol Psychiatry 13(1):36-64.
25. Connolly JJ, Glessner JT, Hakonarson H. 2012. A genome-wide association study of autism incorporating autism diagnostic interview-revised, autism diagnostic observation schedule, and social responsiveness scale. Child Dev DOI: 10.1111/j.1467-8624.2012.01838.x [Epub ahead of print].
26. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE. 2011. A copy number variation morbidity map of developmental delay. Nat Genet 43(9):838-846.
27. Dai N, Foldager L, Gallego JA, Hack LM, Ji Y, Lett TAP, Liu B-C, Loken EK, Mandelli L, Mehta D, Power RA, Sprooten E, Stephens SH, Paska AV, Yan J, Zai CC, Zai G, Zhang-James Y, O'Shea A, DeLisi LE. 2012. Summaries from the XIX World Congress of Psychiatric Genetics, Washington, DC, September 10-14, 2011. Am J Med Genet Part B 159B:128-129.
28. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW. 2007. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315(5816):1267-1270.
29. Dalley JW, Everitt BJ, Robbins TW. 2011. Impulsivity, compulsivity, and top-down cognitive control. Neuron 69(4):680-694.
30. Dias R, Robbins TW, Roberts AC. 1996. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380(6569):69-72.
31. Duong L, Klitten LL, Moller RS, Ingason A, Jakobsen KD, Skjodt C, Didriksen M, Hjalgrim H, Werge T, Tommerup N. 2012. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Am J Med Genet Part B Neuropsychiatr Genet 159B(3):354-358.
32. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Pütz B, Uhr M, Weber P, Deussing JM, Gonik M, Bunck M, Keßler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Nöthen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Müller-Myhsok B, Holsboer F, Binder EB. 2011. TMEM132D, a new candidate for anxiety phenotypes: Evidence from human and mouse studies. Mol Psychiatry 16:647-663.
33. Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW. 2010. Drug addiction endophenotypes: Impulsive versus sensation-seeking personality traits. Biol Psychiatry 68(8):770-773.
34. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. 2012. Abnormal brain structure implicated in stimulant drug addiction. Science 335(6068):601-604.
35. Espeseth T, Christoforou A, Lundervold AJ, Steen VM, Le Hellard S, Reinvang I. 2012. Imaging and cognitive genetics: The Norwegian Cognitive NeuroGenetics sample. Twin Res Hum Genet 15(3):442-452.
36. Etain B, Dumaine A, Bellivier F, Pagan C, Francelle L, Goubran-Botros H, Moreno S, Deshommes J, Moustafa K, Le Dudal K, Mathieu F, Henry C, Kahn JP, Launay JM, Mühleisen TW, Cichon S, Bourgeron T, Leboyer M, Jamain S. 2012. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum Mol Genet 18:4030-4037.
37. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St Clair D, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N, Wellcome Trust Case Control Consortium. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 9:1056-1058.
38. Fromer M, Moran JL, Chambert K, Banks E, Bergen SE, Ruderfer DM, Handsaker RE, McCarroll SA, O'Donovan MC, Owen MJ, Kirov G, Sullivan PF, Hultman CM, Sklar P, Purcell SM. 2012. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet 91:597-607.
39. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, Thibodeau P, Bachand I, Bao JY, Tong AH, Lin CH, Millet B, Jaafari N, Joober R, Dion PA, Lok S, Krebs MO, Rouleau GA. 2011. Increased exonic de novo mutation rate in individuals with SCZ. Nat Genet 43(9):860-863.
40. Girirajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH, Shafer N, Bernier R, Ferrero GB, Silengo M, Warren ST, Moreno CS, Fichera M, Romano C, Raskind WH, Eichler EE. 2011. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 7(11):e1002334.
41. Goes FS, Hamshere ML, Seifuddin F, Pirooznia M, Belmonte-Mahon P, Breuer R, Schulze T, Nöthen M, Cichon S, Rietschel M, Holmans P, Zandi PP, Bipolar Genome Study (BiGS), Craddock N, Potash JB, 2012. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry 2:e180.
42. 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467(7319):1061-1073.
43. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43:969-976.
44. Gymrek M, Golan D, Rosset S, Erlich Y. 2012. lobSTR: A short tandem repeat profiler for personal genomes. Genome Res 22(6):1154-1162.
45. Hampshire A, Owen AM. 2006. Fractionating attentional control using event-related fMRI. Cereb Cortex 16(12):1679-1689.
46. Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. 2006. The CHARGE study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114:1119-1125.
47. Hosak L, Silhan P, Hosakova J. 2012. Genome-wide association studies in SCZ, and potential etiological and functional implications of their results. Acta Med (Hradec Kralove) 55(1):3-11.
48. Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B, Sciaky N, Dutton JW Jr, Lee HM, Chen X, Jin J, Bridges AS, Zylka MJ, Roth BL, Philpot BD. 2011. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481(7380):185-189.
49. Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, Bogdanović D, Geschwind DH, Mane SM, State MW, Sestan N. 2009. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62:494-509.
50. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, Guennel T, Shin Y, Johnson MB, Krsnik Z, Mayer S, Fertuzinhos S, Umlauf S, Lisgo SN, Vortmeyer A, Weinberger DR, Mane S, Hyde TM, Huttner A, Reimers M, Kleinman JE, Sestan N. 2011. Spatio-temporal transcriptome of the human brain. Nature 478:483-489.
51. Keller MC, Visscher PM, Goddard ME. 2011. Quantification of inbreeding due to distant ancestors and its detection using dense single nucleotide polymorphism data. Genetics 189(1):237-249.
52. Klauck SM, Felder B, Kolb-Kokocinski A, Schuster C, Chiocchetti A, Schupp I, Wellenreuther R, Schmoetzer G, Poustka F, Breitenbach-Koller L, Poustka A. 2006. Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol Psychiatry 11:1073-1084.
53. Lee SH, DeCandia TR, Ripke S, Yang J, SCZ Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ), International SCZ Consortium (ISC), Molecular Genetics of SCZ Collaboration (MGS), Sullivan PF, Goddard ME, Keller MC, Visscher PM, Wray NR. 2012. Estimating the proportion of variation in susceptibility to SCZ captured by common SNPs (vol 44, pg 247, 2012). Nat Genet 44(3):247-250.
54. Leergaard TB, Hilgetag CC, Sporns O. 2012. Mapping the connectome: Multi-level analysis of brain connectivity. Front Neuroinform 6:14.
55. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009. Common genetic determinants of SCZ and bipolar disorder in Swedish families: A population-based study. Lancet 373:234-239.
56. Luykx JJ, Vinkers CH, Bakker SC, Visser WF, van Boxmeer L, Strengman E, van Eijk KR, Lens JA, Borgdorff P, Keijzers P, Kappen TH, van Dongen EP, Bruins P, Verhoeven NM, de Koning TJ, Kahn RS, Ophoff RA. 2012. A common variant in ERBB4 regulates GABA concentration in human cerobrospinal fluid. Neuropsychopharmacology 37(9):2088-2092.
57. McGue M, Gottesman II, Rao DC. 1983. The transmission of SCZ under a multifactorial threshold model. Am J Hum Genet 35(6):1161-1178.
58. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD, Steele CJ, Breuer R, Strohmaier J, Wendland JR, Mattheisen M, Mühleisen TW, Maier W, Nöthen MM, Cichon S, Farmer A, Vincent JB, Holsboer F, Preisig M, Rietschel M, Bipolar Disorder Genome Study (BiGS) Consortium. 2010. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 2:128-131.
59. Muhle H, Mefford HC, Obermeier T, von Spiczak S, Eichler EE, Stephani U, Sander T, Helbig I. 2011. Absence seizures with intellectual disability as a phenotype of the 15q13.3 microdeletion syndrome. Epilepsia 52(12):e194-e198.
60. Muhleisen TW, Mattheisen M, Strohmaier J, Degenhardt F, Priebe L, Schultz CC, Breuer R, Meier S, Hoffmann P, Investigators GROUP, Rivandeneira F, Hofman A, Uitterlinden AG, Moebus S, Gieger C, Emeny R, Ladwig KH, Wichmann HE, Schwarz M, Kammerer-Ciernioch J, Schlosser RG, Nenadic I, Sauer H, Mossner R, Maier W, Rujescu D, Lange C, Ophoff RA, Schulze TG, Rietschel M, Nothen MM, Cichon S, 2012. Association between SCZ and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res 138:69-73.
61. Nieratschker V, Grosshans M, Frank J, Strohmaier J, von der Goltz C, El-Maarri O, Witt SH, Cichon S, Nothen MM, Kiefer F, Rietschel M. 2012. Epigenetic alteration of the dopamine transporter gene in alcohol-dependent patients is associated with age. Addict Biol DOI: 10.1111/j.1369-1600.2012.00459.x [Epub ahead of print].
62. Novak NM, Stein JL, Medland SE, Hibar DP, Thompson PM, Toga AW. 2012. EnigmaVis: Online interactive visualization of genome-wide association studies of the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. Twin Res Hum Genet 15(3):414-418.
63. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Hartmann AM, Möller HJ, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, Williams NM, Giegling I, Iwata N, Ikeda M, Darvasi A, Shifman S, He L, Duan J, Sanders AR, Levinson DF, Gejman PV, Cichon S, Nöthen MM, Gill M, Corvin A, Rujescu D, Kirov G, Owen MJ, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Cloninger CR, Molecular Genetics of SCZ Collaboration. 2008. Identification of loci associated with SCZ by genome-wide association and follow-up. Nat Genet 40(9):1053-1055.
64. Palomero-Gallagher N, Schleicher A, Lindemann S, Lessenich A, Zilles K, Loscher W. 2008. Receptor fingerprinting the circling ci2 rat mutant: Insights into brain asymmetry and motor control. Exp Neurol 210(2):624-637.
65. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW. 1997. Frontal-striatal cognitive deficits in patients with chronic SCZ. Brain 120(Pt 10):1823-1843.
66. Parker CC, Cheng R, Sokoloff G, Lim JE, Skol AD, Abney M, Palmer AA. 2011. Fine-mapping alleles for body weight in LG/J×SM/J F(2) and F(34) advanced intercross lines. Mamm Genome 22:563-571.
67. Pedrosa E, Ye K, Nolan KA, Morrell L, Okun JM, Persky AD, et al. 2007. Positive association of schizophrenia to JARID2 gene. Am J Med Genet Part B Neuropsychiatr Genet 144B(1):45-51.
68. Penagarikano O, Geschwind DH. 2012. What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 18(3):156-163.
69. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942-948.
70. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
71. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of SCZ and bipolar disorder. Nature 460(7256):748-752.
72. Radua J, Borgwardt S, Crescini A, Mataix-Cols D, Meyer-Lindenberg A, McGuire PK, Fusar-Poli P. 2012. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci Biobehav Rev 36(10):2325-2333.
73. Rattei T, Tischler P, Gotz S, Jehl MA, Hoser J, Arnold R, Conesa A, Mewes HW. 2010. SIMAP-A comprehensive database of pre-calculated protein sequence similarities, domains, annotations and clusters. Nucleic Acids Res 38:D223-D226.
74. Rietschel M, Mattheisen M, Frank J, Treutlein J, Degenhardt F, Breuer R, Steffens M, Mier D, Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Herms S, Wichmann HE, Schreiber S, Jockel KH, Strohmaier J, Roeske D, Haenisch B, Gross M, Hoefels S, Lucae S, Binder EB, Wienker TF, Schulze TG, Schmal C, Zimmer A, Juraeva D, Brors B, Bettecken T, Meyer-Lindenberg A, Muller-Myhsok B, Maier W, Nothen MM, Cichon S. 2010. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 68:578-585.
75. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, Lin DY, Duan J, Ophoff RA, Andreassen OA, et al. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43(10):969-976.
76. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR. 2009. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta-analysis. JAMA 301:2462-2471.
77. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. 2002. Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99(18):11934-11939.
78. Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V. 2012. A system-level transcriptomic analysis of SCZ using postmortem brain tissue samples. Arch Gen Psychiatry 1-11 DOI: 10.1001/archgenpsychiatry.2012.704 [Epub ahead of print].
79. Shah AK, Tioleco NM, Nolan K, Locker J, Groh K, Villa C, Stopkova P, Pedrosa E, Lachman HM. 2010. Rare NRXN1 promoter variants in patients with SCZ. Neurosci Lett 475(2):80-84.
80. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. 2008. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14.
81. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM. 2008. Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6):558-569.
82. Smith C. 1970. Heritability of liability and concordance in monozygous twins. Ann Hum Genet 34(1):85-91.
83. Smrt RD, Szulwach KE, Pfeiffer RL, Li X, Guo W, Pathania M, Teng ZQ, Luo Y, Peng J, Bordey A, Jin P, Zhao X. 2010. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 28(6):1060-1070.
84. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, Domin M, Grimm O, Hollinshead M, Holmes AJ, Homuth G, Hottenga JJ, Langan C, Lopez LM, Hansell NK, Hwang KS, Kim S, Laje G, Lee PH, Liu X, Loth E, Lourdusamy A, Mattingsdal M, Mohnke S, Maniega SM, Nho K, Nugent AC, O'Brien C, Papmeyer M, Pütz B, Ramasamy A, Rasmussen J, Rijpkema M, Risacher SL, Roddey JC, Rose EJ, Ryten M, Shen L, Sprooten E, Strengman E, Teumer A, Trabzuni D, Turner J, van Eijk K, van Erp TG, van Tol MJ, Wittfeld K, Wolf C, Woudstra S, Aleman A, Alhusaini S, Almasy L, Binder EB, Brohawn DG, Cantor RM, Carless MA, Corvin A, Czisch M, Curran JE, Davies G, de Almeida MA, Delanty N, Depondt C, Duggirala R, Dyer TD, Erk S, Fagerness J, Fox PT, Freimer NB, Gill M, Göring HH, Hagler DJ, Hoehn D, Holsboer F, Hoogman M, Hosten N, Jahanshad N, Johnson MP, Kasperaviciute D, Kent JW Jr, Kochunov P, Lancaster JL, Lawrie SM, Liewald DC, Mandl R, Matarin M, Mattheisen M, Meisenzahl E, Melle I, Moses EK, Mühleisen TW, Nauck M, Nöthen MM, Olvera RL, Pandolfo M, Pike GB, Puls R, Reinvang I, Rentería ME, Rietschel M, Roffman JL, Royle NA, Rujescu D, Savitz J, Schnack HG, Schnell K, Seiferth N, Smith C, Steen VM, Valdés Hernández MC, Van den Heuvel M, van der Wee NJ, Van Haren NE, Veltman JA, Völzke H, Walker R, Westlye LT, Whelan CD, Agartz I, Boomsma DI, Cavalleri GL, Dale AM, Djurovic S, Drevets WC, Hagoort P, Hall J, Heinz A, Jack CR Jr, Foroud TM, Le Hellard S, Macciardi F, Montgomery GW, Poline JB, Porteous DJ, Sisodiya SM, Starr JM, Sussmann J, Toga AW, Veltman DJ, Walter H, Weiner MW, Alzheimer's Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study Group, Bis JC, Ikram MA, Smith AV, Gudnason V, Tzourio C, Vernooij MW, Launer LJ, DeCarli C, Seshadri S, Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium, Andreassen OA, Apostolova LG, Bastin ME, Blangero J, Brunner HG, Buckner RL, Cichon S, Coppola G, de Zubicaray GI, Deary IJ, Donohoe G, de Geus EJ, Espeseth T, Fernández G, Glahn DC, Grabe HJ, Hardy J, Hulshoff Pol HE, Jenkinson M, Kahn RS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meyer-Lindenberg A, Morris DW, Müller-Myhsok B, Nichols TE, Ophoff RA, Paus T, Pausova Z, Penninx BW, Potkin SG, Sämann PG, Saykin AJ, Schumann G, Smoller JW, Wardlaw JM, Weale ME, Martin NG, Franke B, Wright MJ, Thompson PM, Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium. 2012. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44(5):552-561.
85. Steinberg S, Mors O, Borglum AD, Gustafsson O, Werge T, Mortensen PB, Andreassen OA, Sigurdsson E, Thorgeirsson TE, Bottcher Y, Olason P, Ophoff RA, Cichon S, Gudjonsdottir IH, Pietilainen OP, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Athanasiu L, Suvisaari J, Lonnqvist J, Paunio T, Hartmann A, Jurgens G, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Breuer R, Moller HJ, Giegling I, Glenthoj B, Rasmussen HB, Mattheisen M, Bitter I, Rethelyi JM, Sigmundsson T, Fossdal R, Thorsteinsdottir U, Ruggeri M, Tosato S, Strengman E, Genetic Risk and Outcome in Psychosis, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Walshe M, Bramon E, Vassos E, Li T, Fraser G, Walker N, Toulopoulou T, Yoon J, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Peltonen L, Rujescu D, Collier DA, Stefansson H, St Clair D, Stefansson K. 2011. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry 16:59-66.
86. Sullivan PF. 2010. The psychiatric GWAS consortium: Big science comes to psychiatry. Neuron 68(2):182-186.
87. Sullivan PF, Kendler KS, Neale MC. 2003. SCZ as a complex trait-Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12):1187-1192.
88. Sullivan PF, Daly MJ, O'Donovan M. 2012. Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet 13(8):537-551.
89. Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD, Iddon JL, Robbins TW, Sahakian BJ. 2001. Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12(4):265-280.
90. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L, Santistevan NJ, Li W, Zhao X, Jin P. 2010. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 189:127-141.
91. Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, Huang XP, Trapella C, Guerrini R, Calo G, Roth BL, Cherezov V, Stevens RC. 2012. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485(7398):395-399.
92. Visscher PM, Medland SE, Ferreira MA, Morley KI, Zhu G, Cornes BK, Montgomery GW, Martin NG. 2006. Assumption-free estimation of heritability from genome-wide identify-by-descent sharing between full siblings. PLoS Genet 2(3):e41.
93. Whelan R, Conrod PJ, Poline JB, Lourdusamy A, Banaschewski T, Barker GJ, Bellgrove MA, Büchel C, Byrne M, Cummins TD, Fauth-Bühler M, Flor H, Gallinat J, Heinz A, Ittermann B, Mann K, Martinot JL, Lalor EC, Lathrop M, Loth E, Nees F, Paus T, Rietschel M, Smolka MN, Spanagel R, Stephens DN, Struve M, Thyreau B, Vollstaedt-Klein S, Robbins TW, Schumann G, Garavan H, IMAGEN Consortium. 2012. Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci 15(6):920-925.
94. Williams R IV, Lim JE, Harr B, Wing C, Walters R, Distler MG, Teschke M, Wu C, Wiltshire T, Su AI, Sokoloff G, Tarantino LM, Borevitz JO, Palmer AA. 2009. A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS ONE 4:e4649.
95. Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, Duggirala R, Glahn DC. 2010. Cortical thickness or grey matter volume? The importance of selecting the phenotypefor imaging genetics studies. Neuroimage 53(3):1135-1146.
96. Wirgenes KV, Sønderby IE, Haukvik UK, Mattingsdal M, Tesli M, Athanasiu L, Sundet K, Røssberg JI, Dale AM, Brown AA, Agartz I, Melle I, Djurovic S, Andreassen OA. 2012. TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Transl Psychiatry 2:e112.
97. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M. 2011. Exome sequencing supports a de novo mutational paradigm for SCZ. Nat Genet 43(9):864-868.
98. Yang H, Ding Y, Hutchins LN, Szatkiewicz J, Bell TA, Paigen BJ, Graber JH, de Villena FP, Churchill GA. 2009. A customized and versatile high-density genotyping array for the mouse. Nat Methods 6:663-666.
99. Yang J, Visscher PM, Wray NR. 2010. Sporadic cases are the norm for complex disease. Eur J Hum Genet 18(9):1039-1043.
100. Yang J, Manolio TA, Pasquale LR, Boerwinkle E, Caporaso N, Cunningham JM, de Andrade M, Feenstra B, Feingold E, Hayes MG, Hill WG, Landi MT, Alonso A, Lettre G, Lin P, Ling H, Lowe W, Mathias RA, Melbye M, Pugh E, Cornelis MC, Weir BS, Goddard ME, Visscher PM. 2011. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 43(6):519-525.
101. Yang WY, Novembre J, Eskin E, Halperin E. 2012. A model-based approach for analysis of spatial structure in genetic data. Nat Genet 44(6):725-731.
102. Ystrom E, Reichborn-Kjennerud T, Aggen SH, Kendler KS. 2011. Alcohol dependence in men: Reliability and heritability. Alcohol Clin Exp Res 35:1716-1722.
103. Zilles K, Amunts K. 2009. Receptor mapping: Architecture of the human cerebral cortex. Curr Opin Neurol 22(4):331-339.
104. Zilles K, Amunts K. 2010. Centenary of Brodmann's map-Conception and fate. Nat Rev Neurosci 11(2):139-145.
105. Zilles K, Palomero-Gallagher N, Schleicher A. 2004. Transmitter receptors and functional anatomy of the cerebral cortex. J Anat 205(6):417-432.
106. Zovkic IB, Sweatt JD. 2012. Epigenetic mechanisms in learned fear: Implications for PTSD. Neuropsychopharmacology 38(1):77-93.